| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.26 | 7e-05 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0004 |